Paolo Denti
University of Cape Town
H-index: 33
Africa-South Africa
Top articles of Paolo Denti
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Determinants of early change in serum creatinine after initiation of dolutegravir‐based antiretroviral therapy in South Africa | British Journal of Clinical Pharmacology | Rephaim Mpofu Aida N Kawuma Roeland E Wasmann Godspower Akpomiemie Nomathemba Chandiwana | 2024/2/8 |
High-Dose Isoniazid Lacks EARLY Bactericidal Activity Against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized, Phase 2 Clinical Trial | American Journal of Respiratory and Critical Care Medicine | Kamunkhwala Gausi Elisa H Ignatius Veronique De Jager Caryn Upton Soyeon Kim | 2024/4/2 |
Rifampicin and protein concentrations in paired spinal versus ventricular cerebrospinal fluid samples of children with tuberculous meningitis | Journal of Antimicrobial Chemotherapy | Jill Combrinck Phophi Tshavhungwe Ursula Rohlwink Nico Enslin Nqobile Thango | 2024/2 |
Testing Novel Strategies for Patients Hospitalized with HIV-associated Disseminated Tuberculosis (NewStrat-TB): Protocol for a Randomised Controlled Trial | Phiona E Namale Linda Boloko Marcia Vermeulen Kate A Haigh Fortuna Bagula | 2024/4/1 | |
Machine Learning and Artificial Intelligence in PK‐PD Modeling: Fad, Friend, or Foe? | Clinical Pharmacology & Therapeutics | Zhonghui Huang Paolo Denti Hitesh Mistry Frank Kloprogge | 2024/1/5 |
Relationship between tenofovir diphosphate concentrations in dried blood spots and virological outcomes after initiating tenofovir-lamivudine-dolutegravir as first-line or … | JAIDS Journal of Acquired Immune Deficiency Syndromes | Jennifer Kate van Heerden Graeme Meintjes David Barr Ying Zhao Rulan Griesel | 2024/3/1 |
Recoverability of Causal Effects in a Longitudinal Study under Presence of Missing Data | arXiv preprint arXiv:2402.14562 | Anastasiia Holovchak Michael Schomaker Helen McIlleron Paolo Denti | 2024/2/22 |
Linezolid population pharmacokinetic model in plasma and cerebrospinal fluid among patients with tuberculosis meningitis | medRxiv | Noha Abdelgawad Sean Wasserman Mahmoud Tareq Abdelwahab Angharad Davis Cari Stek | 2023 |
Pharmacokinetics and Optimal Dosing of Levofloxacin in Children for Drug-Resistant Tuberculosis: An Individual Patient Data Meta-Analysis | Clinical Infectious Diseases | Yasmine N White Belen P Solans Paolo Denti Louvina E van der Laan H Simon Schaaf | 2024/2/10 |
Assessing potential drug-drug interactions between clofazimine and other frequently used agents to treat drug-resistant tuberculosis | Antimicrobial Agents and Chemotherapy | Allan Kengo Firdaus Nabeemeeah Paolo Denti Ryan Sabet Gifty Okyere-Manu | 2024/4/10 |
The impact of enteral feeding and therapeutic monitoring of rifampicin with dose escalation in critically ill patients with tuberculosis | International Journal of Infectious Diseases | Rubeshan Perumal Kogieleum Naidoo Anushka Naidoo Marothi P Letsoalo Aliasgar Esmail | 2023/1/1 |
A Nanopore sequencing-based pharmacogenomic panel to personalize tuberculosis drug dosing | American Journal of Respiratory and Critical Care Medicine | Renu Verma Kesia Esther da Silva Neesha Rockwood Roeland E Wasmann Nombuso Yende | 2023/9/10 |
Population Pharmacokinetic Analysis of Rifampicin in Plasma, Cerebrospinal Fluid, and Brain Extracellular Fluid in South African Children with Tuberculous Meningitis | Antimicrobial Agents and Chemotherapy | Noha Abdelgawad Mvuwo Tshavhungwe Ursula Rohlwink Helen McIlleron Mahmoud T Abdelwahab | 2023/3/16 |
Pharmacokinetic analysis of linezolid for multidrug resistant tuberculosis at a tertiary care centre in Mumbai, India | Frontiers in Pharmacology | Juan Eduardo Resendiz-Galvan Prerna R Arora Mahmoud Tareq Abdelwahab Zarir F Udwadia Camilla Rodrigues | 2023/1/4 |
Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysis | PLoS medicine | Lufina Tsirizani Galileya Roeland E Wasmann Chishala Chabala Helena Rabie Janice Lee | 2023/11/21 |
Leveraging physiologically based pharmacokinetic modeling to optimize dosing for lopinavir/ritonavir with rifampin in pediatric patients | Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy | Sara N Salerno Edmund V Capparelli Helen McIlleron Jacqueline G Gerhart Julie B Dumond | 2023/7 |
Unexpectedly low drug exposures among Ugandan patients with TB and HIV receiving high-dose rifampicin | Antimicrobial Agents and Chemotherapy | Allan Kengo Kamunkhwala Gausi Ruth Nabisere Joseph Musaazi Allan Buzibye | 2023/11/15 |
Optimizing Moxifloxacin Dose in MDR-TB Participants with or without Efavirenz Coadministration Using Population Pharmacokinetic Modeling | Antimicrobial Agents and Chemotherapy | MT Chirehwa JE Resendiz-Galvan R Court M De Kock L Wiesner | 2023/3/16 |
A Comprehensive Nonlinear Mixed Effects Model of Glucose, Insulin, and C-Peptide Interaction during IVGTT | Edoardo Faggionato Paolo Denti Anna Largajolli Alessandra Bertoldo Chiara DALLA MAN | 2023 | |
Pharmacokinetics and safety of twice-daily ritonavir-boosted atazanavir with rifampicin. | Clinical Infectious Diseases | Kamunkhwala Gausi Henry Mugerwa Marco Siccardi Maiara Camotti Montanha Mohammed Lamorde | 2023/11/20 |
Co-Authors
